Iranian Society of Gynecology Oncology

Document Type : Original Research Article

Author

Department of Obstetric and Gynecological, Medical College, Al-Qadisiyah University, Diwaniya, Iraq

Abstract

Background & Objective: The aim of the current study was comparison of the effectiveness of intravenous iron sucrose versus oral ferrous fumarate for the treatment of iron deficiency anemia during pregnancy.
Materials & Methods: This is a prospective randomized clinical trial enrolling 100 pregnant women with iron deficiency anemia who visited the Al-diwaniya Educational Hospital for maternity and children from October 2022 to July 2023 whose ferritin level was less than 15 ng/ml and Hb level was between 70-10.9g/L. They were treated with either intravenous iron sucrose or oral ferrous fumarate for four weeks.  Formerly, patients were allocated into two groups. The patients in the group I received ferrous fumarate pills, each enclosed with elemental Iron 100 mg.  Group II got 100 ml of 0.9% NaCl containing a dose of iron sucrose dissolved in it and calculated by a specific equation. After four weeks, serum ferritin and hemoglobin levels were assessed, and the adverse effects were also monitored.
Results: Comparing hemoglobin levels produces a substantial pre- and post-treatment difference (P=0.001). Serum Ferritin Level harvest significant differences pre- and post-treatment (P=0.001). The post-treatment comparison of the two groups showed a significant difference in each group (P= 0.001).
Conclusion: Maternal iron reserves are more effectively increased by intravenous ferrous sucrose than by oral ferrous fumarate.

Keywords

Main Subjects

1. Kumar SB, Arnipalli SR, Mehta P, Carrau S, Ziouzenkova O. Iron deficiency anemia: efficacy and limitations of nutritional and comprehensive mitigation strategies. Nutrients. 2022;14(14):2976. [DOI:10.3390/nu14142976] [PMID] [PMCID]
2. Kalaivani K. Prevalence & consequences of anaemia in pregnancy. Indian J Med Res. 2009;130(5):627-33.
3. Noronha JA, Al Khasawneh E, Seshan V, Ramasubramaniam S, Raman S. Anemia in pregnancy-consequences and challenges: a review of literature. J South Asian Fed Obstet Gynecol. 2012;4(1):64-70. [DOI:10.5005/jp-journals-10006-1177]
4. Vural T, Toz E, Ozcan A, Biler A, Ileri A, Inan AH. Can anemia predict perinatal outcomes in different stages of pregnancy? Pak J Med Sci. 2016;32(6):1354-9. [DOI:10.12669/pjms.326.11199] [PMID] [PMCID]
5. De Benoist B, Cogswell M, Egli I, McLean E. Worldwide prevalence of anaemia 1993-2005; WHO Global Database of anaemia. 2008.
6. Batool AH, Ibironke O, Molin W, Donna S, Majid E, Wafaie WF. Anaemia, prenatal iron use, and risk of adverse pregnancy outcomes: systematic review and meta-analysis. Br Med J. 2013;346:f3443. [DOI:10.1136/bmj.f3443] [PMID] [PMCID]
7. Bakhtiar UJ, Khan Y, Nasar R. Relationship between maternal hemoglobin and perinatal outcome. Age. 2007;25:24.
8. Yip R. Prevention and control of iron deficiency: policy and strategy issues. J Nutr. 2002;132(4):802S-5S. [DOI:10.1093/jn/132.4.802S] [PMID]
9. Bayoumeu F, Subiran-Buisset C, Baka N-E, Legagneur H, Monnier-Barbarino P, Laxenaire MC. Iron therapy in iron deficiency anemia in pregnancy: Intravenous route versus oral route. Eur J Obstet Gynecol Reprod Biol. 2005;123:S15-S9. [DOI:10.1016/S0301-2115(05)80402-6]
10. Sharma JB, Soni D. Oxidative stress in pregnancy-Role of iron therapy: oral iron therapy and risk of free radicals. Obstet Gynecol. 2001;6(12):705-6.
11. Perewusnyk G, Huch R, Huch A, Breymann C. Parenteral iron therapy in obstetrics: 8 years experience with iron-sucrose complex. Br J Nutr. 2002;88(1):3-10. [DOI:10.1079/BJN2002577] [PMID]
12. Bhavi SB, Jaju PB. Intravenous iron sucrose v/s oral ferrous fumarate for treatment of anemia in pregnancy. A randomized controlled trial. BMC Pregnancy Childbirth. 2017;17(1):137. [DOI:10.1186/s12884-017-1313-9] [PMID] [PMCID]
13. Di Renzo GC, Spano F, Giardina I, Brillo E, Clerici G, Roura LC. Iron Deficiency Anemia in Pregnancy. Women's Health. 2015;11(6):891-900. [DOI:10.2217/whe.15.35] [PMID]
14. Al RA, Unlubilgin E, Kandemir O, Yalvac S, Cakir L, Haberal A. Intravenous Versus Oral Iron for Treatment of Anemia in Pregnancy: A Randomized Trial. Obstet Gynecol. 2005;106(6):1335-40. [DOI:10.1097/01.AOG.0000185260.82466.b4] [PMID]
15. Radhika AG, Sharma AK, Perumal V, Sinha A, Sriganesh V, Kulshreshtha V, Kriplani A. Parenteral Versus Oral Iron for Treatment of Iron Deficiency Anaemia During Pregnancy and post-partum: A Systematic Review. J Obstet Gynaecol India. 2019;69(1):13-24. [DOI:10.1007/s13224-018-1191-8] [PMID] [PMCID]
16. Reveiz L, Gyte GML, Cuervo LG, Casasbuenas A. Treatments for iron‐deficiency anaemia in pregnancy. Cochrane Database Syst Rev. 2011(10):CD003094. [DOI:10.1002/14651858.CD003094.pub3]
17. Neogi SB, Devasenapathy N, Singh R, Bhushan H, Shah D, Divakar H, et al. Safety and effectiveness of intravenous iron sucrose versus standard oral iron therapy in pregnant women with moderate-to-severe anaemia in India: a multicentre, open-label, phase 3, randomised, controlled trial. Lancet Public Health. 2019;7(12):e1706-e16. [DOI:10.1016/S2214-109X(19)30427-9] [PMID]
18. Kriplani A, Mahey R, Dash BB, Kulshreshta V, Agarwal N, Bhatla N. Intravenous iron sucrose therapy for moderate to severe anaemia in pregnancy. Indian J Med Res. 2013;138(1):78-82.
19. Al-Momen A-K, Al-Meshari A, Al-Nuaim L, Saddique A, Abotalib Z, Khashogji T, Abbas M. Intravenous iron sucrose complex in the treatment of iron deficiency anemia during pregnancy. Eur J Obstet Gynecol Reprod Biol. 1996;69(2):121-4. [DOI:10.1016/0301-2115(95)02538-3] [PMID]